Full Text View
Tabular View
Study Results
Related Studies
A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer
This study has been completed.
Study NCT00371254   Information provided by Bristol-Myers Squibb

First Received on September 1, 2006.   Last Updated on February 18, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial